Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

Adding a second method to PROTACs could improve cancer treatment.

Extracellular vesicles may help prevent and repair spine disc degeneration.

Anti-CD19 therapy may help treat SLE and NMOSD.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Mutations in the spike protein affect drug binding and effectiveness.

AgK114 protein helps in hamster skin injury recovery.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Anti-Ku antibodies are linked to unique symptoms and may involve autophagy issues.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

COVID-19 vaccination may trigger lupus in some people.

Seaweeds contain beneficial compounds with potential uses in food, cosmetics, and health, but more research is needed to improve extraction and safety.